VIRIDIAN THERAPEUTICS INC

Ticker: VRDN CUSIP: 92790C104 Class: Common Stock

MARSHALL WACE, LLP's Holding History (CIK: 0001318757)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 1,375,739 Value ($000) $42,813 Avg Close $27.43 Range $20.69 - $34.04
Q3 2025
Shares 869,188 Value ($000) $18,757 Avg Close $18.04 Range $13.84 - $21.72
Q2 2025
Shares 1,207,871 Value ($000) $16,886 Avg Close $13.57 Range $9.90 - $16.29
Q1 2025
Shares 1,084,040 Value ($000) $14,613 Avg Close $17.03 Range $13.23 - $21.58
Q3 2024
Shares 684,799 Value ($000) $15,579 Avg Close $16.35 Range $11.85 - $23.80
Q2 2024
Shares 72,974 Value ($000) $949 Avg Close $13.84 Range $11.40 - $17.69
Q1 2024
Shares 78,701 Value ($000) $1,378 Avg Close $19.39 Range $16.16 - $24.18
Q4 2023
Shares 301,289 Value ($000) $6,562 Avg Close $15.79 Range $10.93 - $23.53
Q3 2023
Shares 962,493 Value ($000) $14,765 Avg Close $19.08 Range $14.64 - $25.05
Q2 2023
Shares 651,179 Value ($000) $15,492 Avg Close $25.65 Range $21.96 - $30.30
Q1 2023
Shares 629,320 Value ($000) $16,010 Avg Close $32.06 Range $24.76 - $39.00
Q4 2022
Shares 611,457 Value ($000) $17,861 Avg Close $23.04 Range $18.00 - $29.99
Q3 2022
Shares 608,662 Value ($000) $12,483 Avg Close $17.98 Range $10.47 - $26.22
Q2 2022
Shares 444,799 Value ($000) $5,145 Avg Close $13.44 Range $9.47 - $20.18
Q1 2022
Shares 17,563 Value ($000) $326 Avg Close $19.21 Range $15.93 - $21.50
Q4 2021
Shares 88,405 Value ($000) $1,748 Avg Close $18.63 Range $15.18 - $22.00